KRYS Short Selling Activity
Krystal Biotech (KRYS) continues to experience elevated short-selling pressure, remaining on the FINRA Reg SHO threshold list for 77 trading days. The stock currently shows a short interest of 13.7% of the float. While the borrow fee remains at 0.3%, the extended duration on the threshold list suggests that short sellers are maintaining a consistent presence in the stock. This data reflects daily short volume flow, which is a measure of daily selling pressure rather than the total open short interest reported by FINRA on a bi-monthly basis.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.